Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease

Abstract

In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measure